Wu, Tao
Yoon, Hojong http://orcid.org/0000-0002-6062-5489
Xiong, Yuan http://orcid.org/0000-0002-2211-8267
Dixon-Clarke, Sarah E.
Nowak, Radosław P. http://orcid.org/0000-0002-0605-0071
Fischer, Eric S. http://orcid.org/0000-0001-7337-6306
Article History
Received: 5 November 2019
Accepted: 23 April 2020
First Online: 15 June 2020
Competing interests
: E.S.F. is a founder, scientific advisory board (SAB) member and equity holder of Civetta Therapeutics. E.S.F. is a SAB member and equity holder of C4 Therapeutics. E.S.F. is or has consulted for Novartis, AbbVie, Astellas, Deerfield, EcoR1 and Pfizer. The Fischer lab receives or has received research funding from Novartis, Deerfield and Astellas.